Table III.
Predictors of global methylation assessed by univariate general linear model (cases = 176 and controls = 173)
| Variables | Among controls | Among all participants (cases + controls) | ||||
| Mean ± SE of 5-mdC | β | P value | Mean ± SE of 5-mdCa | βb | P valueb | |
| Total | 4.38 ± 0.03 | 4.28 ± 0.02 | ||||
| Age (continuous) | 0.001 | 0.730 | <0.001 | 0.996 | ||
| <Median (55) | 4.41 ± 0.04 | 4.30 ± 0.03 | ||||
| +Median (55) | 4.34 ± 0.04 | −0.068 | 0.208 | 4.26 ± 0.03 | −0.043 | 0.263 | 
| Race | ||||||
| Caucasian | 4.38 ± 0.03 | 4.27 ± 0.02 | ||||
| African-American | 4.41 ± 0.08 | −0.032 | 0.781 | 4.31 ± 0.06 | −0.036 | 0.646 | 
| Batch (category on date) | −0.001 | 0.776 | 0.004 | 0.248 | ||
| Family history of BRCA | ||||||
| Yes | 4.36 ± 0.03 | 4.27 ± 0.02 | ||||
| No | 4.43 ± 0.06 | 0.069 | 0.300 | 4.29 ± 0.05 | 0.030 | 0.532 | 
| Education | ||||||
| ≤high school | 4.35 ± 0.07 | 4.25 ± 0.04 | ||||
| >high school | 4.38 ± 0.03 | 0.033 | 0.624 | 4.28 ± 0.02 | 0.036 | 0.429 | 
| BMI (continuous) | 0.001 | 0.790 | 0.002 | 0.496 | ||
| <25 | 4.37 ± 0.04 | 4.26 ± 0.03 | ||||
| 25–29.9 | 4.34 ± 0.04 | 4.26 ± 0.03 | ||||
| 30+ | 4.39 ± 0.06 | 0.012 | 0.730 | 4.28 ± 0.04 | 0.009 | 0.717 | 
| Smoking habit | ||||||
| Never | 4.38 ± 0.04 | 4.25 ± 0.03 | ||||
| Ever | 4.37 ± 0.04 | −0.007 | 0.904 | 4.30 ± 0.03 | 0.043 | 0.272 | 
| Pack-year (continuous) | 0.001 | 0.534 | <0.001 | 0.766 | ||
| Never smoker | 4.38 ± 0.04 | 4.25 ± 0.03 | ||||
| Below median | 4.37 ± 0.06 | 4.30 ± 0.05 | ||||
| At or above median | 4.37 ± 0.06 | −0.005 | 0.891 | 4.27 ± 0.04 | 0.009 | 0.716 | 
| Alcohol consumption habit | ||||||
| Never | 4.45 ± 0.07 | 4.33 ± 0.05 | ||||
| Ever | 4.36 ± 0.03 | −0.087 | 0.209 | 4.26 ± 0.02 | −0.076 | 0.109 | 
| Alcohol drinking frequency (continuous) | −0.004 | 0.334 | Less than –0.001 | 0.929 | ||
| Never | 4.45 ± 0.07 | 4.33 ± 0.05 | ||||
| <median | 4.42 ± 0.04 | 4.29 ± 0.03 | ||||
| +median | 4.30 ± 0.04 | −0.078 | 0.031 | 4.23 ± 0.03 | −0.053 | 0.036 | 
| Age at menarche | ||||||
| <13 | 4.41 ± 0.04 | 4.30 ± 0.03 | ||||
| +13 | 4.35 ± 0.04 | −0.055 | 0.334 | 4.26 ± 0.03 | −0.036 | 0.375 | 
| Age at first birth | ||||||
| <25 | 4.34 ± 0.04 | 4.28 ± 0.03 | ||||
| +25 | 4.36 ± 0.05 | 4.25 ± 0.03 | ||||
| Nulliparous | 4.47 ± 0.06 | 0.062 | 0.080 | 4.31 ± 0.04 | 0.013 | 0.596 | 
| Parity (continuous) | −0.004 | 0.884 | −0.002 | 0.916 | ||
| Nulliparous | 4.47 ± 0.06 | 4.27 ± 0.04 | ||||
| 1–2 | 4.36 ± 0.04 | 4.26 ± 0.03 | ||||
| 3+ | 4.34 ± 0.04 | −0.062 | 0.086 | 4.31 ± 0.03 | −0.021 | 0.424 | 
| Menopausal status | ||||||
| Premenopausal | 4.38 ± 0.04 | 4.28 ± 0.03 | ||||
| Postmenopausal | 4.37 ± 0.04 | −0.001 | 0.982 | 4.27 ± 0.03 | −0.013 | 0.736 | 
| Age at menopause | ||||||
| Premenopausal | 4.38 ± 0.04 | 4.28 ± 0.03 | ||||
| <50 | 4.46 ± 0.05 | 4.31 ± 0.04 | ||||
| +50 | 4.27 ± 0.06 | −0.042 | 0.220 | 4.22 ± 0.04 | −0.026 | 0.271 | 
| HRTc | ||||||
| Never | 4.37 ± 0.03 | 4.28 ± 0.02 | ||||
| Ever | 4.38 ± 0.05 | 0.015 | 0.824 | 4.27 ± 0.04 | −0.012 | 0.793 | 
| Multivitamin use | ||||||
| Never or occasionally | 4.39 ± 0.05 | 4.31 ± 0.03 | ||||
| Regularly | 4.37 ± 0.03 | −0.004 | 0.892 | 4.25 ± 0.03 | −0.023 | 0.303 | 
BMI, body mass index; BRCA, breast cancer; HRT, hormone replacement therapy.
Least square means adjusted for group (case and control) status.
Adjusting for group (case and control) status.
Adjusting for menopausal status.